Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery

on behalf of the N3C Consortium

Research output: Contribution to journalComment/debatepeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)1305-1308
Number of pages4
JournalAnnals of Surgical Oncology
Volume30
Issue number3
DOIs
StatePublished - Mar 2023

Cite this